RENAISSANCE TECHNOLOGIES LLC
Position in NERV — Minerva Neurosciences, Inc.
CIK 1037389
NEW YORK, NY
Position in NERV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$406,815
-$133,627 QoQ
Shares Held
73,300
-18.3% QoQ
Ownership
0.154%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 58 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NERV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. NERV ranks #221 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in NERV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $406,815 | 73,300 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $540,442 | 89,700 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $599,784 | 149,200 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $245,232 | 116,500 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $190,920 | 111,000 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $193,964 | 114,097 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $284,638 | 128,100 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $419,724 | 157,200 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $534,963 | 167,700 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $458,633 | 177,765 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $659,280 | 107,200 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $649,980 | 94,200 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $898,462 | 98,300 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $177,280 | 110,800 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $175,377 | 110,300 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $939,614 | 101,800 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $117,872 | 35,611 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $323,660 | 389,952 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $473,471 | 591,100 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,312,161 | 754,116 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,324,278 | 1,001,844 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,282,172 | 439,100 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,605,820 | 686,248 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,059,686 | 647,700 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,590,175 | 717,500 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $4,238,682 | 704,100 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||